MGX

Metagenomi Therapeutics, Inc. - Common Stock (MGX)

About Metagenomi Therapeutics, Inc. - Common Stock (MGX)

Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Details

Daily high
$0.78
Daily low
$0.71
Price at open
$0.78
52 Week High
$2.28
52 Week Low
$0.71
Market cap
29.8M
Dividend yield
-
Volume
117,747
Avg. volume
157,876
P/E ratio
-.32

Metagenomi Therapeutics, Inc. - Common Stock News

Details

Daily high
$0.78
Daily low
$0.71
Price at open
$0.78
52 Week High
$2.28
52 Week Low
$0.71
Market cap
29.8M
Dividend yield
-
Volume
117,747
Avg. volume
157,876
P/E ratio
-.32